N Engl J Med 2015;373:224757.ArticlePubMed 49
Patients should maintain regular contact with their diabetes care team and report any concerns about hypoglycaemia, particularly if taking GLP-1 medications alongside other glucose-lowering agents such as sulphonylureas or insulin
Melanotan I Research Applications Melanotan I occupies a specific and unusually load-bearing position in melanocortin receptor pharmacology, because its radioiodinated form is the field's default radioligand
SNAP/FLAG-tagged human GLP-1Rs (SNAP/FLAG-hGLP-1Rs) with single alanine substitutions for each selected residue were successfully expressed in INS-1 832/3 GLP-1R KO cells with no significant differences detected in cell surface expression levels versus WT GLP-1R (Figure 2H, top graph)
Contraindications: Not for use in individuals with cancer, those who are pregnant/breastfeeding, or anyone under 18 years of age
Youre dealing with GLP-1 side effects